Replies to post #23345 on Elite Pharmaceuticals Inc (ELTP)

[Drugdoctor]

I'm very happy! This revenue reported was all PRODUCT SALES for the most part, compared to milestone payments that increased revenues in the previous quarter. Thanks for point that out Hike!

[gordonhoochie]

Good synopsis Hike, really gives you an indication of what is to come once the full pipeline gets rollings aside from 216 and 154 stuff.

[tangerine]

Accounts receivable and inventories up about 25%.

Accounts receivable is up to 500k

Inventory at 400k

AR is basically revenue not yet recognized or paid by the end customer.

This is very good

[Hike]

I made a mistake here so correcting:

Phentermine:
Elite’s revenue derived from phentermine 37.5mg tablets during the three months ended June 30, 2012 and 2011 were approximately $162k and $217k, respectively, with such amounts including manufacturing revenues, royalties and a $145k milestone payment triggered by the shipment of the product in April 2011.

Take the 145k out of the 2011 number they went from 72k to 162k


Lodrane:
Elite’s revenue derived from Lodrane D® during the three months ended June 30, 2012 and 2011 were approximately $142k and zero, respectively.

Methadone:
Elite’s revenues derived from the contract manufacture of Methadone 10mg tablets during the three months ended June 30, 2012 and 2011 were approximately $128k and zero, respectively.


Hydromorphone:
Elite’s revenues derived from Hydromorphone 8mg tablets during the three months ended June 30, 2012 and 2011 were approximately $78k and zero, respectively, with such amounts including manufacturing revenues and royalties paid pursuant to the Precision Dose Agreement.

All combined they went from: 72k to 510k (In one quarter) on these four items since last year.